课题基金 / 基金详情

Ionic movement and tolerance to ischemia in congenital heart disease : Sodium movement via the Na^+/H^+ exchange during reoxygenation is a determinant of post-ischemic functional recovery in the rat myocardium

Ionic movement and tolerance to ischemia in congenital heart disease : Sodium movement via the Na^+/H^+ exchange during reoxygenation is a determinant of post-ischemic functional recovery in the rat myocardium
先天性心脏病中的离子运动和缺血耐受性:再氧合过程中通过 Na^ /H^ 交换进行的钠运动是大鼠心肌缺血后功能恢复的决定因素
批准号:
16591383
负责人:
YAMAMOTO Hiroshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

YAMAMOTO Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
目的:探讨复氧过程中Na+/H+交换抑制对心功能恢复的影响,以及Na+/HCO3^-共转运体在钠离子运动中的作用。方法:用Krebs-Henseleit碳酸氢盐缓冲液灌流大鼠离体心,常温(37℃)全心缺血20分钟后再灌流(37℃),以确定钠离子运动是否为心功能恢复的决定因素。(1)100μ二甲基阿米洛利(DMA)在再灌流前10min(方案I)或缺氧再灌注5min(方案II)后10min给予。Ii)在再灌流的前10分钟使用无碳酸氢钠的HEPES缓冲液(方案III)。结果:1)在方案I和方案II中,DMA组缺血后左室发展压(%LVdP)恢复明显高于对照组(方案II分别为68.6±5.9和52.0±6.1%,方案II分别为66.6±2.8和52.0±5.5%)。在方案III中,无碳酸氢组与对照组相比差异无统计学意义(分别为35.9±4.9和24.7±6.7%)。结论:复氧过程中钠离子通过Na+/H+交换运动是心功能恢复的决定因素。Na~+/HCO3~+共转运体可能不参与再灌流过程中钠离子的运动。
英文摘要
Objectives : To determine whether or not sodium ion movement during reoxygenation is a determinant of post-ischemic recovery of cardiac function, we examined i) the effect of Na^+/H^+ exchange inhibition during reperfusion or reoxygenation on post-ischemic recovery of cardiac function and ii) the involvement of Na+/HCO_3^-cotransporter in the sodium ion movement.Methods : Isolated rat hearts were Langendorff-perfused with Krebs-Henseleit bicarbonate buffer and subjected to 20 minutes of normothermic (37C) global ischemia followed by normothermic (37℃) reperfusion. i) 100 μM dimethyl amiloride (DMA) was given during the first 10 min of reperfusion (protocol I) or for 10 minutes after 5-minute hypoxic reperfusion (protocol II). ii) a bicarbonate-free HEPES buffer was used during the first 10 minutes of reperfusion (protocol III). All the protocols were then followed by 25 minutes of noromoxic reperfusion.Results : i) In protocols I and II, the post-ischemic recovery of left ventricular developed pressure (%LVDP) was significantly greater in the DMA group than in the control group (68.6±5.9 vs. 52.0±6.1%, respectively in protocol Land 66.6±2.8 vs. 52.0±5.5%, respectively in protocol II). In protocol III, there was no difference between the bicarbonate-free group and the control group (35.9±4.9 vs. 24.7±6.7%, respectively).Conclusions : Sodium ion movement via the Na^+/H^+ exchange during reoxygenation is a determinant of post-ischemic recovery of cardiac function. The Na^+/HCO_3^- cotransporter may not be involved in the sodium ion movement during reperfusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishment of Innovative Method to Create Metal/Semiconductor Junctions in One Piece of Single Walled Carbon Nanotube
  • 批准号:
    16K14236
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2016
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
A study on an integrated model of perceived employability: From the viewpoint of international comparison and longitudinal comparison
  • 批准号:
    24530473
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2012
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
Development of the human tissue-equivalent phantom for millimeter wave range
  • 批准号:
    24700462
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $1.41万
  • 财政年份:
    2012
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
Newly Proposal for Chirality Control of Single-Walled Carbon Nanotubes by Resonance Photo-Excitation
  • 批准号:
    24560383
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2012
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
国内基金
海外基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李轶
  • 依托单位:
TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
  • 批准号:
    82371142
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘君
  • 依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题